Inflammatory disorders
Scientists find potential therapy for fatty liver disease
Metabolic dysfunction-associated steatotic liver disease (MASLD)—previously known as "non-alcoholic fatty liver disease"—affects about 25% of the global population. Its severe form, metabolic dysfunction-associated steatohepatitis ...
11 hours ago
0
0